Selected research
Industry Research
Compounded Topical Drug Industry Research Report 2026
Market perspective
The global Compounded Topical Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Compounded Topical Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Compounded Topical Drug market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Compounded Topical Drug market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Compounded Topical Drug include Triangle Compounding Pharmacy, QuVa Pharma, PharMEDium Services, Pharmaca Integrative Pharmacy, Perrigo Company plc, PCCA (Professional Compounding Centers of America), Nephron Pharmaceuticals Corporation, Medisca and Lorraine’s Pharmacy, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Compounded Topical Drug market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Compounded Topical Drug.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Compounded Topical Drug Market by Company
Triangle Compounding Pharmacy
QuVa Pharma
PharMEDium Services
Pharmaca Integrative Pharmacy
Perrigo Company plc
PCCA (Professional Compounding Centers of America)
Nephron Pharmaceuticals Corporation
Medisca
Lorraine’s Pharmacy
Institutional Pharmacy Solutions
Fresenius Kabi
Fagron
Custom Scripts Pharmacy
Central Admixture Pharmacy Services (CAPS)
CareFirst Specialty Pharmacy
Cantrell Drug Company
B. Braun Melsungen AG Company
Avella Specialty Pharmacy
Atlas Pharmaceuticals
Compounded Topical Drug Segment by Type
Ointments
Lotions
Cream
Gels
Compounded Topical Drug Segment by Application
Hospitals
Retail Pharmacy
Other
Compounded Topical Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Compounded Topical Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Compounded Topical Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Compounded Topical Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Compounded Topical Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Ointments
- Lotions
- Cream
- Gels
Applications
- Hospitals
- Retail Pharmacy
- Other
Companies covered
- Triangle Compounding Pharmacy
- QuVa Pharma
- PharMEDium Services
- Pharmaca Integrative Pharmacy
- Perrigo Company plc
- PCCA (Professional Compounding Centers of America)
- Nephron Pharmaceuticals Corporation
- Medisca
- Lorraine’s Pharmacy
- Institutional Pharmacy Solutions
- Fresenius Kabi
- Fagron
- Custom Scripts Pharmacy
- Central Admixture Pharmacy Services (CAPS)
- CareFirst Specialty Pharmacy
- Cantrell Drug Company
- B. Braun Melsungen AG Company
- Avella Specialty Pharmacy
- Atlas Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Compounded Topical Drug by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Ointments
- 2.2.3 Lotions
- 2.2.4 Cream
- 2.2.5 Gels
- 2.3 Compounded Topical Drug by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Retail Pharmacy
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Compounded Topical Drug Breakdown Data by Type
- 3.1 Global Compounded Topical Drug Historic Market Size by Type (2021-2026)
- 3.2 Global Compounded Topical Drug Forecasted Market Size by Type (2027-2032)
4 Compounded Topical Drug Breakdown Data by Application
- 4.1 Global Compounded Topical Drug Historic Market Size by Application (2021-2026)
- 4.2 Global Compounded Topical Drug Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Compounded Topical Drug Market Perspective (2021-2032)
- 5.2 Global Compounded Topical Drug Growth Trends by Region
- 5.2.1 Global Compounded Topical Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Compounded Topical Drug Historic Market Size by Region (2021-2026)
- 5.2.3 Compounded Topical Drug Forecasted Market Size by Region (2027-2032)
- 5.3 Compounded Topical Drug Market Dynamics
- 5.3.1 Compounded Topical Drug Industry Trends
- 5.3.2 Compounded Topical Drug Market Drivers
- 5.3.3 Compounded Topical Drug Market Challenges
- 5.3.4 Compounded Topical Drug Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Compounded Topical Drug Players by Revenue
- 6.1.1 Global Top Compounded Topical Drug Players by Revenue (2021-2026)
- 6.1.2 Global Compounded Topical Drug Revenue Market Share by Players (2021-2026)
- 6.2 Global Compounded Topical Drug Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Compounded Topical Drug Head Office and Area Served
- 6.4 Global Compounded Topical Drug Players, Product Type & Application
- 6.5 Global Compounded Topical Drug Manufacturers Established Date
- 6.6 Global Compounded Topical Drug Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Compounded Topical Drug Market Size (2021-2032)
- 7.2 North America Compounded Topical Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Compounded Topical Drug Market Size by Country (2021-2026)
- 7.4 North America Compounded Topical Drug Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Compounded Topical Drug Market Size (2021-2032)
- 8.2 Europe Compounded Topical Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Compounded Topical Drug Market Size by Country (2021-2026)
- 8.4 Europe Compounded Topical Drug Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Compounded Topical Drug Market Size (2021-2032)
- 9.2 Asia-Pacific Compounded Topical Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Compounded Topical Drug Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Compounded Topical Drug Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Compounded Topical Drug Market Size (2021-2032)
- 10.2 South America Compounded Topical Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Compounded Topical Drug Market Size by Country (2021-2026)
- 10.4 South America Compounded Topical Drug Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Compounded Topical Drug Market Size (2021-2032)
- 11.2 Middle East & Africa Compounded Topical Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Compounded Topical Drug Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Compounded Topical Drug Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Triangle Compounding Pharmacy
- 12.1.1 Triangle Compounding Pharmacy Company Information
- 12.1.2 Triangle Compounding Pharmacy Business Overview
- 12.1.3 Triangle Compounding Pharmacy Revenue in Compounded Topical Drug Business (2021-2026)
- 12.1.4 Triangle Compounding Pharmacy Compounded Topical Drug Product Portfolio
- 12.1.5 Triangle Compounding Pharmacy Recent Developments
- 12.2 QuVa Pharma
- 12.2.1 QuVa Pharma Company Information
- 12.2.2 QuVa Pharma Business Overview
- 12.2.3 QuVa Pharma Revenue in Compounded Topical Drug Business (2021-2026)
- 12.2.4 QuVa Pharma Compounded Topical Drug Product Portfolio
- 12.2.5 QuVa Pharma Recent Developments
- 12.3 PharMEDium Services
- 12.3.1 PharMEDium Services Company Information
- 12.3.2 PharMEDium Services Business Overview
- 12.3.3 PharMEDium Services Revenue in Compounded Topical Drug Business (2021-2026)
- 12.3.4 PharMEDium Services Compounded Topical Drug Product Portfolio
- 12.3.5 PharMEDium Services Recent Developments
- 12.4 Pharmaca Integrative Pharmacy
- 12.4.1 Pharmaca Integrative Pharmacy Company Information
- 12.4.2 Pharmaca Integrative Pharmacy Business Overview
- 12.4.3 Pharmaca Integrative Pharmacy Revenue in Compounded Topical Drug Business (2021-2026)
- 12.4.4 Pharmaca Integrative Pharmacy Compounded Topical Drug Product Portfolio
- 12.4.5 Pharmaca Integrative Pharmacy Recent Developments
- 12.5 Perrigo Company plc
- 12.5.1 Perrigo Company plc Company Information
- 12.5.2 Perrigo Company plc Business Overview
- 12.5.3 Perrigo Company plc Revenue in Compounded Topical Drug Business (2021-2026)
- 12.5.4 Perrigo Company plc Compounded Topical Drug Product Portfolio
- 12.5.5 Perrigo Company plc Recent Developments
- 12.6 PCCA (Professional Compounding Centers of America)
- 12.6.1 PCCA (Professional Compounding Centers of America) Company Information
- 12.6.2 PCCA (Professional Compounding Centers of America) Business Overview
- 12.6.3 PCCA (Professional Compounding Centers of America) Revenue in Compounded Topical Drug Business (2021-2026)
- 12.6.4 PCCA (Professional Compounding Centers of America) Compounded Topical Drug Product Portfolio
- 12.6.5 PCCA (Professional Compounding Centers of America) Recent Developments
- 12.7 Nephron Pharmaceuticals Corporation
- 12.7.1 Nephron Pharmaceuticals Corporation Company Information
- 12.7.2 Nephron Pharmaceuticals Corporation Business Overview
- 12.7.3 Nephron Pharmaceuticals Corporation Revenue in Compounded Topical Drug Business (2021-2026)
- 12.7.4 Nephron Pharmaceuticals Corporation Compounded Topical Drug Product Portfolio
- 12.7.5 Nephron Pharmaceuticals Corporation Recent Developments
- 12.8 Medisca
- 12.8.1 Medisca Company Information
- 12.8.2 Medisca Business Overview
- 12.8.3 Medisca Revenue in Compounded Topical Drug Business (2021-2026)
- 12.8.4 Medisca Compounded Topical Drug Product Portfolio
- 12.8.5 Medisca Recent Developments
- 12.9 Lorraine’s Pharmacy
- 12.9.1 Lorraine’s Pharmacy Company Information
- 12.9.2 Lorraine’s Pharmacy Business Overview
- 12.9.3 Lorraine’s Pharmacy Revenue in Compounded Topical Drug Business (2021-2026)
- 12.9.4 Lorraine’s Pharmacy Compounded Topical Drug Product Portfolio
- 12.9.5 Lorraine’s Pharmacy Recent Developments
- 12.10 Institutional Pharmacy Solutions
- 12.10.1 Institutional Pharmacy Solutions Company Information
- 12.10.2 Institutional Pharmacy Solutions Business Overview
- 12.10.3 Institutional Pharmacy Solutions Revenue in Compounded Topical Drug Business (2021-2026)
- 12.10.4 Institutional Pharmacy Solutions Compounded Topical Drug Product Portfolio
- 12.10.5 Institutional Pharmacy Solutions Recent Developments
- 12.11 Fresenius Kabi
- 12.11.1 Fresenius Kabi Company Information
- 12.11.2 Fresenius Kabi Business Overview
- 12.11.3 Fresenius Kabi Revenue in Compounded Topical Drug Business (2021-2026)
- 12.11.4 Fresenius Kabi Compounded Topical Drug Product Portfolio
- 12.11.5 Fresenius Kabi Recent Developments
- 12.12 Fagron
- 12.12.1 Fagron Company Information
- 12.12.2 Fagron Business Overview
- 12.12.3 Fagron Revenue in Compounded Topical Drug Business (2021-2026)
- 12.12.4 Fagron Compounded Topical Drug Product Portfolio
- 12.12.5 Fagron Recent Developments
- 12.13 Custom Scripts Pharmacy
- 12.13.1 Custom Scripts Pharmacy Company Information
- 12.13.2 Custom Scripts Pharmacy Business Overview
- 12.13.3 Custom Scripts Pharmacy Revenue in Compounded Topical Drug Business (2021-2026)
- 12.13.4 Custom Scripts Pharmacy Compounded Topical Drug Product Portfolio
- 12.13.5 Custom Scripts Pharmacy Recent Developments
- 12.14 Central Admixture Pharmacy Services (CAPS)
- 12.14.1 Central Admixture Pharmacy Services (CAPS) Company Information
- 12.14.2 Central Admixture Pharmacy Services (CAPS) Business Overview
- 12.14.3 Central Admixture Pharmacy Services (CAPS) Revenue in Compounded Topical Drug Business (2021-2026)
- 12.14.4 Central Admixture Pharmacy Services (CAPS) Compounded Topical Drug Product Portfolio
- 12.14.5 Central Admixture Pharmacy Services (CAPS) Recent Developments
- 12.15 CareFirst Specialty Pharmacy
- 12.15.1 CareFirst Specialty Pharmacy Company Information
- 12.15.2 CareFirst Specialty Pharmacy Business Overview
- 12.15.3 CareFirst Specialty Pharmacy Revenue in Compounded Topical Drug Business (2021-2026)
- 12.15.4 CareFirst Specialty Pharmacy Compounded Topical Drug Product Portfolio
- 12.15.5 CareFirst Specialty Pharmacy Recent Developments
- 12.16 Cantrell Drug Company
- 12.16.1 Cantrell Drug Company Company Information
- 12.16.2 Cantrell Drug Company Business Overview
- 12.16.3 Cantrell Drug Company Revenue in Compounded Topical Drug Business (2021-2026)
- 12.16.4 Cantrell Drug Company Compounded Topical Drug Product Portfolio
- 12.16.5 Cantrell Drug Company Recent Developments
- 12.17 B. Braun Melsungen AG Company
- 12.17.1 B. Braun Melsungen AG Company Company Information
- 12.17.2 B. Braun Melsungen AG Company Business Overview
- 12.17.3 B. Braun Melsungen AG Company Revenue in Compounded Topical Drug Business (2021-2026)
- 12.17.4 B. Braun Melsungen AG Company Compounded Topical Drug Product Portfolio
- 12.17.5 B. Braun Melsungen AG Company Recent Developments
- 12.18 Avella Specialty Pharmacy
- 12.18.1 Avella Specialty Pharmacy Company Information
- 12.18.2 Avella Specialty Pharmacy Business Overview
- 12.18.3 Avella Specialty Pharmacy Revenue in Compounded Topical Drug Business (2021-2026)
- 12.18.4 Avella Specialty Pharmacy Compounded Topical Drug Product Portfolio
- 12.18.5 Avella Specialty Pharmacy Recent Developments
- 12.19 Atlas Pharmaceuticals
- 12.19.1 Atlas Pharmaceuticals Company Information
- 12.19.2 Atlas Pharmaceuticals Business Overview
- 12.19.3 Atlas Pharmaceuticals Revenue in Compounded Topical Drug Business (2021-2026)
- 12.19.4 Atlas Pharmaceuticals Compounded Topical Drug Product Portfolio
- 12.19.5 Atlas Pharmaceuticals Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst